Stock Scorecard
Stock Summary for Cerus Corp (CERS) - $1.82 as of 12/3/2025 8:05:54 PM EST
Total Score
6 out of 30
Safety Score
21 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for CERS
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for CERS
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for CERS
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for CERS
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for CERS (21 out of 100)
| Stock Price Rating (Max of 10) | 2 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 1 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for CERS
Financial Details for CERS
Company Overview |
|
|---|---|
| Ticker | CERS |
| Company Name | Cerus Corp |
| Country | USA |
| Description | Cerus Corporation (CERS) is a leading biomedical products company dedicated to enhancing blood safety through its innovative INTERCEPT Blood System, which effectively inactivates pathogens in blood components. Based in Concord, California, Cerus employs cutting-edge technology to address the essential requirements of transfusion medicine, thereby ensuring improved patient safety. With a strong and expanding portfolio, the company is well-positioned to meet the growing global demand for safe blood products, while advancing blood safety protocols and making a meaningful contribution to public health initiatives. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 1.82 |
| Price 4 Years Ago | 6.81 |
| Last Day Price Updated | 12/3/2025 8:05:54 PM EST |
| Last Day Volume | 1,531,447 |
| Average Daily Volume | 1,281,480 |
| 52-Week High | 2.23 |
| 52-Week Low | 1.12 |
| Last Price to 52 Week Low | 62.50% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 45.50 |
| Sector PE | 88.06 |
| 5-Year Average PE | -16.92 |
| Free Cash Flow Ratio | 22.75 |
| Industry Free Cash Flow Ratio | 27.49 |
| Sector Free Cash Flow Ratio | 28.78 |
| Current Ratio Most Recent Quarter | 1.89 |
| Total Cash Per Share | 0.08 |
| Book Value Per Share Most Recent Quarter | 0.32 |
| Price to Book Ratio | 5.64 |
| Industry Price to Book Ratio | 4.38 |
| Sector Price to Book Ratio | 33.12 |
| Price to Sales Ratio Twelve Trailing Months | 1.80 |
| Industry Price to Sales Ratio Twelve Trailing Months | 5.92 |
| Sector Price to Sales Ratio Twelve Trailing Months | 15.97 |
| Analyst Buy Ratings | 3 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 192,088,000 |
| Market Capitalization | 349,600,160 |
| Institutional Ownership | 71.72% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 44.20% |
| Reported EPS 12 Trailing Months | -0.08 |
| Reported EPS Past Year | -0.07 |
| Reported EPS Prior Year | -0.11 |
| Net Income Twelve Trailing Months | -15,964,000 |
| Net Income Past Year | -20,918,000 |
| Net Income Prior Year | -37,489,000 |
| Quarterly Revenue Growth YOY | 14.50% |
| 5-Year Revenue Growth | 19.28% |
| Operating Margin Twelve Trailing Months | 2.35% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 15,670,000 |
| Total Cash Past Year | 20,266,000 |
| Total Cash Prior Year | 11,647,000 |
| Net Cash Position Most Recent Quarter | -32,985,000 |
| Net Cash Position Past Year | -44,596,000 |
| Long Term Debt Past Year | 64,862,000 |
| Long Term Debt Prior Year | 59,796,000 |
| Total Debt Most Recent Quarter | 48,655,000 |
| Equity to Debt Ratio Past Year | 0.46 |
| Equity to Debt Ratio Most Recent Quarter | 0.56 |
| Total Stockholder Equity Past Year | 56,145,000 |
| Total Stockholder Equity Prior Year | 52,650,000 |
| Total Stockholder Equity Most Recent Quarter | 61,463,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 168,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 0.00 |
| Free Cash Flow Past Year | 8,522,000 |
| Free Cash Flow Prior Year | -47,765,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.05 |
| MACD Signal | 0.03 |
| 20-Day Bollinger Lower Band | 1.11 |
| 20-Day Bollinger Middle Band | 1.47 |
| 20-Day Bollinger Upper Band | 1.83 |
| Beta | 1.57 |
| RSI | 59.48 |
| 50-Day SMA | 1.48 |
| 150-Day SMA | 1.88 |
| 200-Day SMA | 2.56 |
System |
|
| Modified | 12/3/2025 8:00:32 PM EST |